Allucent are helping small- to mid-sized biotechs stay nimble.
How do small biotechs bursting with innovation leverage the toolbox of big pharma?
Enter Allucent, led by CEO Paula Brown Stafford, who are turbocharging drug developers worldwide!
I had the pleasure of catching up with Paula at JPM Week 2025.
Yours sincerely,
Dr. Adil Ali
Lexicon's latest drug for obesity and weight management has a novel mechanism and is backed by Novo Nordisk.
FLIM LABS is redesigning the tools of fluorescence-lifetime imaging to enable broader access across medicine, pharma, and environmental science.
Ever thought a probiotic could help manage blood sugar by stimulating GLP-1?
Peter DeYoung lends insights on the strategic approach behind Piramal Phama’s expansion and growth.
